Trials / Withdrawn
WithdrawnNCT01818154
Validation of a New Hand Held Light Emitting Diode Device for the Determination of Minimal Erythema Dose (MED)
Validation of a New Hand Held Light Emitting Diode (LED) Device for the Determination of Minimal Erythema Dose (MED) for Narrowband Ultraviolet B.
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Henry Ford Health System · Academic / Other
- Sex
- All
- Age
- 18 Years – 120 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to validate a new hand held light emitting diode (LED) device for the measurement of minimal erythema dose (MED) for narrow band Ultraviolet B (UVB) radiation by comparing to the traditional approach of measurement of the minimal erythema dose.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | LED phototherapy | |
| OTHER | narrowband UVB phototherapy |
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2013-12-01
- Completion
- 2013-12-01
- First posted
- 2013-03-26
- Last updated
- 2022-03-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01818154. Inclusion in this directory is not an endorsement.